Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
Enacts the "public university emergency contraception education act" requiring public universities to develop, produce and distribute informational materials related to emergency contraception.
This bill creates a certification process for organizations providing in-home substance use disorder treatment services in New York. It requires applicants (including out-of-state entities registered with the state) to meet specific clinical standards, including conducting screenings for overdose risk, mental health conditions, and suicide risk. Certified providers must implement safety plans, medication-assisted treatment, naloxone access, and regular recovery planning. The law aims to standardize and expand access to in-home treatment while ensuring providers meet defined safety and clinical requirements.
Establishes an intensive addiction and medical services integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and medical services integrated services to individuals who have significant addiction and medical issues.
This bill updates New York's legal process for cases where criminal charges are terminated due to a defendant's mental disease or defect. It requires courts to dismiss all criminal charges and arrange for discharge planning (including referrals to outpatient services when clinically appropriate) when a defendant is committed under a final order of observation. Institutions like hospitals must track and report on these referrals through biennial submissions, while the state must publish annual data online about case numbers, originating counties, inpatient care details, and referral outcomes. These changes aim to standardize post-termination care coordination and transparency without altering criminal liability for the defendant.
This bill (S 8801) allows local health officials to request autopsy and toxicology reports related to deaths for public health purposes. It directly affects local health officials and coroners/medical examiners, who must provide these records within strict timeframes: 3 business days for deaths within the official's district, or up to 7 days for out-of-district requests involving residents. The bill specifies that requests are valid when a death occurs within the district or when a resident had a related injury, treatment, or was found deceased in the district. Officials must maintain logs for out-of-district requests and provide written requests to the relevant health official within 3 business days. The policy change streamlines access to death-related data for public health monitoring without altering death certification processes.
Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.
Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.
Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.
Directs the department of health to establish an alternative payment methodology (APM) for federally qualified health centers to preserve and improve patient access to fertility care.
